Genetic Profiling by Single-nucleotide Polymorphism-based Array Analysis Defines Three Distinct Subtypes of Orbital Meningioma

Overview

Journal Brain Pathol

Date 2014 Apr 30

PMID 24773246

Citations 7

Authors

Cheng-Ying Ho

Stacy Mosier

Janice Safneck

Diva R Salomao

Neil R Miller

Charles G Eberhart

Christopher D Gocke

Denise A S Batista

Fausto J Rodriguez

Affiliations

Soon will be listed here.

Abstract

Orbital meningiomas can be classified as primary optic nerve sheath (ON) meningiomas, primary intraorbital ectopic (Ob) meningiomas and spheno-orbital (Sph-Ob) meningiomas based on anatomic site. Single-nucleotide polymorphism (SNP)-based array analysis with the Illumina 300K platform was performed on formalin-fixed, paraffin-embedded tissue from 19 orbital meningiomas (5 ON, 4 Ob and 10 Sph-Ob meningiomas). Tumors were World Health Organization (WHO) grade I except for two grade II meningiomas, and one was NF2-associated. We found genomic alterations in 68% (13 of 19) of orbital meningiomas. Sph-Ob tumors frequently exhibited monosomy 22/22q loss (70%; 7/10) and deletion of chromosome 1p, 6q and 19p (50% each; 5/10). Among genetic alterations, loss of chromosome 1p and 6q were more frequent in clinically progressive tumors. Chromosome 22q loss also was detected in the majority of Ob meningiomas (75%; 3/4) but was infrequent in ON meningiomas (20%; 1/5). In general, Ob tumors had fewer chromosome alterations than Sph-Ob and ON tumors. Unlike Sph-Ob meningiomas, most of the Ob and ON meningiomas did not progress even after incomplete excision, although follow-up was limited in some cases. Our study suggests that ON, Ob and Sph-Ob meningiomas are three molecularly distinct entities. Our results also suggest that molecular subclassification may have prognostic implications.

Citing Articles

Expressions of Progesterone Receptor of Orbital Meningiomas in Indonesia.

Janah R, Rujito L, Wahyono D Asian Pac J Cancer Prev. 2022; 23(12):4137-4143.

PMID: 36579995 PMC: 9971458. DOI: 10.31557/APJCP.2022.23.12.4137.

somatic mosaicism in a patient with bilateral optic nerve sheath meningiomas: illustrative case.

Kaidonis G, Pekmezci M, Van Ziffle J, Auguste K, Horton J J Neurosurg Case Lessons. 2022; 3(23):CASE2247.

PMID: 35733823 PMC: 9204931. DOI: 10.3171/CASE2247.

Synthesizing Molecular and Immune Characteristics to Move Beyond WHO Grade in Meningiomas: A Focused Review.

Kannapadi N, Shah P, Mathios D, Jackson C Front Oncol. 2022; 12:892004.

PMID: 35712492 PMC: 9194503. DOI: 10.3389/fonc.2022.892004.

Spheno-Orbital Meningiomas: Optimizing Visual Outcome.

Menon S, O S, Anand D, Menon G J Neurosci Rural Pract. 2020; 11(3):385-394.

PMID: 32753802 PMC: 7394617. DOI: 10.1055/s-0040-1709270.

Neurofibromatosis type 2 gene mutation and progesterone receptor messenger RNA expression in the pathogenesis of sporadic orbitocranial meningioma.

Supartoto A, Mahayana I, Heriyanto D, Sasongko M, Respatika H, Sakti D Int J Ophthalmol. 2019; 12(4):571-576.

PMID: 31024808 PMC: 6469556. DOI: 10.18240/ijo.2019.04.07.

References

Smith M, OSullivan J, Bhaskar S, Hadfield K, Poke G, Caird J . Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas. Nat Genet. 2013; 45(3):295-8. DOI: 10.1038/ng.2552. View

Cunliffe I, Moffat D, Hardy D, Moore A . Bilateral optic nerve sheath meningiomas in a patient with neurofibromatosis type 2. Br J Ophthalmol. 1992; 76(5):310-2. PMC: 504265. DOI: 10.1136/bjo.76.5.310. View

Bacci C, Sestini R, Provenzano A, Paganini I, Mancini I, Porfirio B . Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation. Neurogenetics. 2009; 11(1):73-80. DOI: 10.1007/s10048-009-0204-2. View

Dumanski J, Rouleau G, Nordenskjold M, Collins V . Molecular genetic analysis of chromosome 22 in 81 cases of meningioma. Cancer Res. 1990; 50(18):5863-7. View

Demonte F, Smith H, Al-Mefty O . Outcome of aggressive removal of cavernous sinus meningiomas. J Neurosurg. 1994; 81(2):245-51. DOI: 10.3171/jns.1994.81.2.0245. View

Perry A, Gutmann D, Reifenberger G . Molecular pathogenesis of meningiomas. J Neurooncol. 2005; 70(2):183-202. DOI: 10.1007/s11060-004-2749-0. View

Christiaans I, Kenter S, Brink H, van Os T, Baas F, van den Munckhof P . Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas. J Med Genet. 2010; 48(2):93-7. DOI: 10.1136/jmg.2010.082420. View

Perez-Magan E, de Lope A, Ribalta T, Ruano Y, Campos-Martin Y, Perez-Bautista G . Differential expression profiling analyses identifies downregulation of 1p, 6q, and 14q genes and overexpression of 6p histone cluster 1 genes as markers of recurrence in meningiomas. Neuro Oncol. 2010; 12(12):1278-90. PMC: 3018937. DOI: 10.1093/neuonc/noq081. View

Aavikko M, Li S, Saarinen S, Alhopuro P, Kaasinen E, Morgunova E . Loss of SUFU function in familial multiple meningioma. Am J Hum Genet. 2012; 91(3):520-6. PMC: 3511996. DOI: 10.1016/j.ajhg.2012.07.015. View

10.

Turbin R, Pokorny K . Diagnosis and treatment of orbital optic nerve sheath meningioma. Cancer Control. 2004; 11(5):334-41. DOI: 10.1177/107327480401100508. View

11.

Andrews D, Faroozan R, Yang B, Hudes R, Werner-Wasik M, Kim S . Fractionated stereotactic radiotherapy for the treatment of optic nerve sheath meningiomas: preliminary observations of 33 optic nerves in 30 patients with historical comparison to observation with or without prior surgery. Neurosurgery. 2002; 51(4):890-902; discussion 903-4. DOI: 10.1097/00006123-200210000-00007. View

12.

Ozaki S, Nishizaki T, Ito H, Sasaki K . Comparative genomic hybridization analysis of genetic alterations associated with malignant progression of meningioma. J Neurooncol. 1999; 41(2):167-74. DOI: 10.1023/a:1006086723607. View

13.

Reuss D, Piro R, Jones D, Simon M, Ketter R, Kool M . Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations. Acta Neuropathol. 2013; 125(3):351-8. DOI: 10.1007/s00401-013-1093-x. View

14.

Shields J, Shields C, Scartozzi R . Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1. Ophthalmology. 2004; 111(5):997-1008. DOI: 10.1016/j.ophtha.2003.01.002. View

15.

Goutagny S, Bah A, Henin D, Parfait B, Bozorg Grayeli A, Sterkers O . Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: clinical, radiological, and molecular features. Neuro Oncol. 2012; 14(8):1090-6. PMC: 3408259. DOI: 10.1093/neuonc/nos129. View

16.

van den Munckhof P, Christiaans I, Kenter S, Baas F, Hulsebos T . Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri. Neurogenetics. 2011; 13(1):1-7. DOI: 10.1007/s10048-011-0300-y. View

17.

Tabernero M, Maillo A, Nieto A, Diez-Tascon C, Lara M, Sousa P . Delineation of commonly deleted chromosomal regions in meningiomas by high-density single nucleotide polymorphism genotyping arrays. Genes Chromosomes Cancer. 2012; 51(6):606-17. DOI: 10.1002/gcc.21948. View

18.

Jansen M, Mohapatra G, Betensky R, Keohane C, Louis D . Gain of chromosome arm 1q in atypical meningioma correlates with shorter progression-free survival. Neuropathol Appl Neurobiol. 2011; 38(2):213-9. PMC: 3563294. DOI: 10.1111/j.1365-2990.2011.01222.x. View

19.

Clark V, Erson-Omay E, Serin A, Yin J, Cotney J, Ozduman K . Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science. 2013; 339(6123):1077-80. PMC: 4808587. DOI: 10.1126/science.1233009. View

20.

Sulman E, White P, Brodeur G . Genomic annotation of the meningioma tumor suppressor locus on chromosome 1p34. Oncogene. 2004; 23(4):1014-20. DOI: 10.1038/sj.onc.1206623. View